IGF2BP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by recognizing the m6A modification of FN1
Arab Journal of Gastroenterology · 2026-11 · 27 (4) · 484-492
DOI: 10.1016/j.ajg.2026.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arab Journal of Gastroenterology, 2026-11. Verfasst von Qirilatu Sa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary and Pancreatosplenic Surgery, Inner Mongolia People's Hospital, No.20, Zhaowuda Road, Saihan District, Hohhot City, Inner Mongolia Auto…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, RNA-Binding Proteins, Fibronectins. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND STUDY AIMS Although advances have been made in intrahepatic cholangiocarcinoma (ICC) treatment, ICC prognosis remains unsatisfactory. Thus, in-depth exploration of ICC pathogenesis to identify new therapeutic targets is crucial for optimizing treatment strategies. PATIENTS AND METHODS Acquisition of single-cell sequencing data encompassing ICC tumor tissues and adjacent normal tissues was performed via the GEO database. Key cell populations and genes were screened through cell annotation, differential expression gene analysis, and KEGG enrichment analysis. In constructed in vitro cell models, qPCR and western blot were respectively implemented to capture mRNA and protein expression levels. Cell migration, proliferation, and invasion abilities were assessed via wound healing, EdU, and Transwell invasion assays. RIP assay was implemented to evaluate RNA-protein interactions, and MeRIP-qPCR was employed to detect m6A modification levels on RNA. RESULTS Bioinformatics analysis revealed an evident increase in the proportion of cholangiocytes in ICC tumor tissues compared to adjacent normal tissues. Within the IGF2BP1 + Malignant subpopulation, which had the highest malignancy score, the expression of IGF2BP1 and FN1 was significantly upregulated. Cellular experiments demonstrated that IGF2BP1 recognizes the m6A modification on FN1 mRNA, thereby stabilizing its expression. Furthermore, significant enhancement of ICC cell proliferation, migration, and invasion capabilities resulted from IGF2BP1 overexpression, while FN1 knockdown markedly attenuated these promoting effects. CONCLUSION Through recognition of the m6A modification on FN1 mRNA, IGF2BP1 facilitates the proliferative, migratory, and invasive capabilities of ICC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary and Pancreatosplenic Surgery, Inner Mongolia People's Hospital, No.20, Zhaowuda Road, Saihan District, Hohhot City, Inner Mongolia Autonomous Region 010017, China.
- Hepatobiliary and Pancreatosplenic Surgery, Inner Mongolia People's Hospital, No.20, Zhaowuda Road, Saihan District, Hohhot City, Inner Mongolia Autonomous Region 010017, China. Electronic address: asigen6017@163.com.
Zitieren
APA
Sa, Q., Wang, X., Jia, G., Wang, X., Su, R., & Sigen, A. (2026). IGF2BP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by recognizing the m6A modification of FN1. Arab Journal of Gastroenterology, 27(4), 484-492. https://doi.org/10.1016/j.ajg.2026.07.005
Vancouver
Sa Q, Wang X, Jia G, Wang X, Su R, Sigen A. IGF2BP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by recognizing the m6A modification of FN1. Arab Journal of Gastroenterology. 2026;27(4):484-492. doi:10.1016/j.ajg.2026.07.005
BibTeX
@article{Sa2026,
author = {Sa, Qirilatu and Wang, Xiaodong and Jia, Guangpeng and Wang, Xidong and Su, Riguga and Sigen, A},
title = {IGF2BP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by recognizing the m6A modification of FN1},
journal = {Arab Journal of Gastroenterology},
year = {2026},
volume = {27},
number = {4},
pages = {484--492},
doi = {10.1016/j.ajg.2026.07.005}
}
EUVIMED